✦ LIBER ✦

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

✍ Scribed by Hotta, N.; Akanuma, Y.; Kawamori, R.; Matsuoka, K.; Oka, Y.; Shichiri, M.; Toyota, T.; Nakashima, M.; Yoshimura, I.; Sakamoto, N.; Shigeta, Y.

Book ID: 125990128
Publisher: American Diabetes Association
Year: 2006
Tongue: English
Weight: 225 KB
Volume: 29
Category: Article
ISSN: 0149-5992
DOI: 10.2337/dc05-2370

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical investigation of epalrestat, an

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: Multicenter study

✍ Nigishi Hotta; Nobuo Sakamoto; Yukio Shigeta; Ryuichi Kikkawa; Yoshio Goto 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Long-term effect of epalrestat, an aldos

Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in Type 2 diabetic patients

✍ Kaoru Iso; Hisaya Tada; Koji Kuboki; Toshiki Inokuchi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB

The effects of zenarestat, an aldose red

The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats

✍ Yukinori Shimoshige; Kyoko Ikuma; Tadashi Yamamoto; Shoji Takakura; Ikuo Kawamur 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Long-term clinical effects of epalrestat

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neurop

✍ Hotta, N.; Kawamori, R.; Fukuda, M.; Shigeta, Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Effect of 24 weeks of treatment with epa

Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

✍ Kenzo Uchida; Toshikazu Kigoshi; Shigeru Nakano; Takashi Ishii; Mitsutaka Kitaza 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Effects of epalrestat, an aldose reducta

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of Nɛ-carboxymethyl lysine

✍ Toshihide Kawai; Izumi Takei; Mikiya Tokui; Osamu Funae; Kazunori Miyamoto; Mits 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 434 KB